IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
၄၀.၆၅ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၄ ၁၅:၃၉:၁၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSEY...
Mkt. cap
ဋေ ၁.၂၀ ထ
Avg. vol.
၁.၄၀ ထောင်
Volume
၂၂၀.၀၀
52-wk high
၅၁.၁၀ US$
52-wk low
၃၂.၆၈ US$
Beta
၀.၄၁
Shares outstanding
၃၃.၅၃ ကုဋေ
No. of employees
၆ ထောင်
Mkt. cap
ဋေ ၁.၂၀ ထ
Avg. vol.
၁.၄၀ ထောင်
Volume
၂၂၀.၀၀
52-wk high
၅၁.၁၀ US$
52-wk low
၃၂.၆၈ US$
Beta
၀.၄၁
Shares outstanding
၃၃.၅၃ ကုဋေ
No. of employees
၆ ထောင်
News stories
From web sources and news partners
CNBC
·
ပြီးခဲ့သည့် ၁ နာရီ
Jim Cramer says the bull market's remarkable 4-year run offers a crucial lesson for investors
New York Post
·
ပြီးခဲ့သည့် ၅၈ မိနစ်
NYSE's opening bell honors Italian Americans who beat stereotypes to reach pinnacle of finance
Yahoo
·
ပြီးခဲ့သည့် ၂၃ မိနစ်
Nasdaq ends lower as oil prices surge ahead of earnings, economic data
Investor's Business Daily
·
ပြီးခဲ့သည့် ၂ နာရီ
Dow Jones Futures: Micron, Nvidia Lead AI Trade Lower; Apple, Meta Rally Near Buy Points
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen ADR Rep 1/4 Ord Shs